Marieke van Rosmalen

Chapter 8 150 demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher. Eur. J. Neurol. 2010;17:356–363. 20. Breiner A, Brannagan TH. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve 2014;50:40– 46. 21. Rajabally YA, Nicolas G, Piéret F, et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: A multicentre European study. J. Neurol. Neurosurg. Psychiatry 2009;80:1364–1368. 22. Van Schaik IN, Léger JM, Nobile-Orazio E, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First revis. J Peripher Nerv Syst 2010;15:295–301. 23. Olney RK, Lewis RA, Putnam TD, Campellone J V. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle and Nerve 2003;27:117–121. 24. Van Den Berg-Vos RM, Franssen H, Wokke JHJ, et al. Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment. Ann. Neurol. 2000;48:919–926. 25. van Es HW, van den Berg LH, Franssen H, et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997;48:1218–1224. 26. Castillo M, Mukherji SK. MRI of enlarged dorsal ganglia, lumbar nerve roots, and cranial nerves in polyradiculoneuropathies. Neuroradiology 1996;38:516–520. 27. Duggins AJ, Mcleod JG, Pollard JD, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999;1383–1390. 28. Morgan GW, Barohn RJ, Bazan III C, et al. Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. NeurologyNeurology 1993;43:618–620. 29. Eurelings M, Notermans NC, Franssen H, et al. MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy. Muscle and Nerve 2001;24:1312–1318. 30. Oudeman J, Eftimov F, Strijkers GJ, et al. Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies. Neurology 2020;94:e62–e74. 31. Goedee HS, VanDer PolWL, VanAsseldonk JTH, et al. Diagnostic value of sonography in treatment- naive chronic inflammatory neuropathies. Neurology 2017;88:143–151. 32. Herraets IJT, Goedee HS, Telleman JA, et al. Nerve ultrasound for the diagnosis of chronic inflammatory neuropathy: a multicenter validation study. Neurology 2020;95:e1745–e1753. 33. Tazawa K-I, Matsuda M, Yoshida T, et al. Spinal Nerve Root Hypertrophy on MRI: Clinical Significance in the Diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Intern. Med. 2008;47:2019–2024. 34. Hiwatashi A, Togao O, Yamashita K, et al. Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI). Eur. J. Radiol. 2017;27:447–453. 35. Tanaka K, Mori N, Yokota Y, Suenaga T. MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study. BMJ Open 2013;3:e003443. 36. vanEsMA,HardimanO,ChioA, et al.Amyotrophic lateral sclerosis. Lancet 2017;390:2084–2098. 37. Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 2015;85:498–504. 38. Combarros O, Calleja J, Polo JM, Berciano J. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol. Scand. 1987;75:9–12. 39. Theadom A, Roxburgh R, MacAulay E, et al. Prevalence of Charcot-Marie-Tooth disease across the lifespan: A population-based epidemiological